gliclazide has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JX; He, L; Lin, Z; Luo, H; Qi, Q; Yao, W; Zhang, C; Zhang, JC | 1 |
1 other study(ies) available for gliclazide and Parkinson Disease
| Article | Year |
|---|---|
18β-glycyrrhetinic acid ameliorates MPTP-induced neurotoxicity in mice through activation of microglial anti-inflammatory phenotype.
Topics: Animals; Anti-Inflammatory Agents; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Parkinson Disease; Phenotype | 2023 |